These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31966518)

  • 1. Downregulation of miR-381 is associated with poor prognosis in papillary thyroid carcinoma.
    Huang T; Yi D; Xu L; Bu E; Zhu C; Sang J; Zhang Y
    Int J Clin Exp Pathol; 2017; 10(12):11610-11616. PubMed ID: 31966518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
    Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
    Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma.
    Wen Q; Wang Y; Li X; Jin X; Wang G
    J Clin Lab Anal; 2021 Jan; 35(1):e23560. PubMed ID: 33368640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-22 may be a biomarker for papillary thyroid cancer.
    Wang D; Guo C; Kong T; Mi G; Li J; Sun Y
    Oncol Lett; 2019 Mar; 17(3):3355-3361. PubMed ID: 30867770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
    Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
    Li M; Song Q; Li H; Lou Y; Wang L
    PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of serum miR-26a predicts poor clinical outcome of papillary thyroid carcinoma.
    Ren G; Li H; He X; Zhang J
    Int J Clin Exp Pathol; 2017; 10(8):9042-9047. PubMed ID: 31966775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.
    Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X
    World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miR-323 as a Biomarker for Screening Papillary Thyroid Cancer From Healthy Controls.
    Liu Y; Li L; Liu Z; Yuan Q; Lu X
    Front Med (Lausanne); 2020; 7():122. PubMed ID: 32478079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
    Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z
    Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
    Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
    PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma.
    Xu D; Su C; Guo L; Yan H; Wang S; Yuan C; Chen G; Pang L; Zhang N
    Open Life Sci; 2019 Jan; 14():275-287. PubMed ID: 33817161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microRNA-182 expression level and its potential prognostic value for papillary thyroid carcinoma.
    Yao XG; Tan Q; Liu PP; Feng LJ
    Int J Clin Exp Pathol; 2019; 12(8):3128-3133. PubMed ID: 31934155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
    Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up.
    Rosignolo F; Sponziello M; Giacomelli L; Russo D; Pecce V; Biffoni M; Bellantone R; Lombardi CP; Lamartina L; Grani G; Durante C; Filetti S; Verrienti A
    J Endocr Soc; 2017 Jan; 1(1):3-13. PubMed ID: 29264441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.